Cambiar Investors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,168
Closed -$833K 157
2024
Q4
$833K Sell
9,168
-732
-7% -$69.9K 0.03% 136
2024
Q3
$1.03M Sell
9,900
-396,333
-98% -$40.4M 0.04% 131
2024
Q2
$39.4M Sell
406,233
-5,728
-1% -$528K 1.54% 28
2024
Q1
$37.1M Sell
411,961
-161,716
-28% -$13.7M 1.38% 33
2023
Q4
$45.7M Buy
573,677
+378
+0.1% +$28.4K 1.8% 18
2023
Q3
$40.8M Buy
573,299
+8,846
+2% +$661K 1.73% 22
2023
Q2
$43.5M Sell
564,453
-90,105
-14% -$6.97M 1.84% 18
2023
Q1
$49.2M Buy
654,558
+36,300
+6% +$2.7M 2.12% 8
2022
Q4
$48.7M Sell
618,258
-3,520
-0.6% -$264K 2.22% 6
2022
Q3
$43.7M Sell
621,778
-4,463
-0.7% -$350K 2.2% 6
2022
Q2
$50.2M Sell
626,241
-16,311
-3% -$1.28M 2.23% 7
2022
Q1
$48.7M Sell
642,552
-16,228
-2% -$1.29M 1.83% 24
2021
Q4
$56.2M Sell
658,780
-7,320
-1% -$572K 1.93% 17
2021
Q3
$50.3M Buy
666,100
+2,185
+0.3% +$174K 1.72% 23
2021
Q2
$54M Buy
663,915
+70,964
+12% +$5.8M 1.74% 20
2021
Q1
$46.7M Buy
592,951
+56,620
+11% +$4.44M 1.63% 23
2020
Q4
$45.9M Buy
536,331
+12,426
+2% +$1.03M 1.79% 19
2020
Q3
$40.4M Sell
523,905
-30,553
-6% -$2.33M 1.84% 19
2020
Q2
$40.6M Sell
554,458
-7,756
-1% -$551K 1.86% 17
2020
Q1
$37.3M Buy
+562,214
New +$39.7M 1.88% 16

Other funds holding CL

Cambiar Investors's CL Position: Q1 2025 in Review

Cambiar Investors sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 9,168 shares — an estimated $833K sold.

Cambiar Investors first reported a position in CL in Q1 2020 and held it in 20 quarters. The position peaked at $56.2M in Q4 2021. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Cambiar Investors reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • Cambiar Investors sold 9,168 Colgate-Palmolive shares in Q1 2025, an estimated $833K.
  • Cambiar Investors first reported a position in Colgate-Palmolive in Q1 2020 and held it in 20 quarters.
  • Cambiar Investors's Colgate-Palmolive position peaked at $56.2M in Q4 2021.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Cambiar Investors's 13F filing for Q1 2025, filed 13 May 2025.